BiotechTube
Home/Novilla Pharmaceuticals/Ajay Kori
AK

Ajay Kori

Managing Director

Novilla Pharmaceuticals

Therapeutic Areas

GoutGeneral PainDiabetic Circulatory InsufficiencyMuscle SpasmsJoint Inflammation

Novilla Pharmaceuticals Pipeline

DrugIndicationPhase
NOV-1776Not explicitly stated (likely General Pain/Joint Inflammation)Phase 2
Pipeline ProgramGoutPre-clinical

Leadership Team at Novilla Pharmaceuticals

DS
Dr. Shashi Kori
Chief Executive Officer
DT
Dr. Tracey Rapp
Vice President of Product Development
DR
Dr. Richard Tubb
Chairman of the Scientific Advisory Board
DE
Dr. Eric Fossel
CoFounder
View full Novilla Pharmaceuticals profile